CollPlant Biotechnologies Ltd.
CLGN
$1.47
-$0.03-2.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | 17.30% | -173.06% | -12.92% | -6.54% | |
| Total Depreciation and Amortization | -14.79% | -1.88% | 0.00% | -3.40% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -3.01% | 19.77% | -47.86% | 4.89% | |
| Change in Net Operating Assets | -110.74% | 94.25% | 130.46% | 310.41% | |
| Cash from Operations | -47.72% | -4.91% | 5.71% | 29.92% | |
| Capital Expenditure | 74.24% | 40.06% | 43.45% | 20.21% | |
| Sale of Property, Plant, and Equipment | -98.53% | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 100.00% | 3.39% | -- | -1,141.18% | |
| Cash from Investing | 84.41% | 34.60% | 43.45% | -22.37% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -100.00% | -98.88% | -100.00% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -100.00% | -98.88% | -100.00% | |
| Foreign Exchange rate Adjustments | -69.85% | 27.16% | 56.38% | 118.68% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -37.49% | -2.18% | -12.20% | 20.29% | |